Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |